Valuation: EMV Capital plc

Market Cap 14.96M 20.19M 17.47M 16.31M 28.14M 1.92B 28.59M 191M 75.11M 963M 75.82M 74.16M 3.18B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.93M 18.8M 16.27M 15.19M 26.21M 1.79B 26.62M 178M 69.95M 897M 70.61M 69.07M 2.97B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 4.05x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
3 months+18.89%
6 months-4.46%
Current year-6.14%
1 week 52.99
Extreme 52.99
55
1 month 51.25
Extreme 51.25
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 01/05/2020
Director of Finance/CFO 45 01/12/2025
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 14/10/2019
Director/Board Member 47 09/12/2022
Chairman 61 01/02/2023
Date Insider Type Main position Quantity % Market Cap.
1/8/26 A Buy 7,000 0.0250%
1/8/26 A Sell 7,000 0.0250%
12/19/25 A Buy

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+2.88%-15.08% 20.19M
+1.17%+1.96%+65.40%+24.79% 3.56B
+1.17%+5.05%-11.49%+1.00% 3.18B
-0.40%-0.60%+44.10%+25.38% 2.04B
+0.94%+6.43%+74.97%+155.34% 1.38B
0.00%0.00%-1.72%-8.60% 727M
+0.42%+13.52%+119.66%+187.25% 535M
-2.03%+1.40%-3.33%-7.05% 408M
0.00%0.00%-44.44%-75.18% 389M
0.00%-2.79%-2.79%-12.55% 367M
Average +0.13%+1.85%+24.32%+27.53% 1.26B
Weighted average by Cap. +0.62%+2.70%+34.30%+32.84%

Financials

2026 *2027 *
Net sales 3.43M 4.63M 4M 3.74M 6.45M 440M 6.55M 43.86M 17.22M 221M 17.38M 17M 730M 3.75M 5.06M 4.38M 4.09M 7.06M 482M 7.17M 47.99M 18.84M 242M 19.02M 18.6M 799M
Net income - -
Net Debt -1.03M -1.39M -1.2M -1.12M -1.94M -132M -1.97M -13.16M -5.16M -66.23M -5.21M -5.1M -219M 233K 314K 272K 254K 438K 29.9M 445K 2.98M 1.17M 14.99M 1.18M 1.15M 49.54M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., CetroMed Limited, NetScientific America, Inc., EMV Director Services Limited, EMV Capital Technology Limited, and ProAxsis Limited, among others.
Employees
21
Date Price Change Volume
07/08/26 GBX 53.50 0.00% 1,705
06/08/26 GBX 53.50 -0.93% 0
05/08/26 GBX 54.00 0.00% 22,060
04/08/26 GBX 54.00 +1.89% 8,364
03/08/26 GBX 53.00 -0.93% 28,640
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5350GBP
Average target price
1.320GBP
Spread / Average Target
+146.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock